A bill to amend title XIX of the Social Security Act to require the Secretary of Health and Human Services to conduct surveys of non-retail pharmacy drug prices, and for other purposes.
Latest action (29 Sep 2026): Introduced
What this bill does
This bill, S. 5586, sponsored by Senator Mark Warner, is titled "A bill to amend title XIX of the Social Security Act to require the Secretary of Health and Human Services to conduct surveys of non-retail pharmacy drug prices, and for other purposes." Its stated purpose is to introduce requirements for the Secretary of Health and Human Services to survey drug prices at pharmacies that do not sell directly to the public.
The bill's focus on non-retail pharmacy drug prices could potentially affect entities involved in these types of transactions within the healthcare system, including pharmacies and those who purchase drugs from them. The "other purposes" mentioned in the title suggest there may be additional, but unspecified, components to the bill. The full details of these effects are not yet available as the official text of the bill has not been published.
S. 5586 was introduced in the Senate on September 29, 2026, and its current status is "Introduced." This means it has just entered the legislative process. The next steps would involve committee review, potential amendments, and then a vote in the Senate, followed by consideration in the House of Representatives if it passes the Senate.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on September 29, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does S. 5586 do?
- This bill, S. 5586, sponsored by Senator Mark Warner, is titled "A bill to amend title XIX of the Social Security Act to require the Secretary of Health and Human Services to conduct surveys of non-retail pharmacy drug prices, and for other purposes." Its stated purpose is to introduce requirements for the Secretary of Health and Human Services to survey drug prices at pharmacies that do not sell directly to the public. The bill's focus on non-retail pharmacy drug prices could potentially affect entities involved in these types of transactions within the healthcare system, including pharmacies and those who purchase drugs from them. The "other purposes" mentioned in the title suggest there may be additional, but unspecified, components to the bill. The full details of these effects are not yet available as the official text of the bill has not been published. S. 5586 was introduced in the Senate on September 29, 2026, and its current status is "Introduced." This means it has just entered the legislative process. The next steps would involve committee review, potential amendments, and then a vote in the Senate, followed by consideration in the House of Representatives if it passes the Senate.
- Has S. 5586 become law?
- Not yet. As of 29 Sep 2026, S. 5586 is introduced.
- Who sponsored S. 5586?
- S. 5586 was sponsored by Sen. Mark Warner [D-VA] (Democrat-VA), with 0 cosponsors.
- What's the latest action on S. 5586?
- Introduced (29 Sep 2026).
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.